Ignite Creation Date:
2025-12-24 @ 4:36 PM
Ignite Modification Date:
2025-12-24 @ 4:36 PM
Study NCT ID:
NCT06839066
Status:
RECRUITING
Last Update Posted:
2025-11-24
First Post:
2025-02-18
Is Possible Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
A Phase II Study to Evaluate HLX43 in Subjects With Recurrent/Metastatic Nasopharyngeal Carcinoma Failed or Intolerance to Second-line Therapy
Sponsor:
Shanghai Henlius Biotech
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2025-04-02
Start Date Type:
ACTUAL
Primary Completion Date:
2026-11-22
Primary Completion Date Type:
ESTIMATED
Completion Date:
2027-11-22
Completion Date Type:
ESTIMATED
First Submit Date:
2025-02-18
First Submit QC Date:
None
Study First Post Date:
2025-02-21
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-11-18
Last Update Post Date:
2025-11-24
Last Update Post Date Type:
ESTIMATED